Apellis Pharmaceuticals, Inc. faces a Sell rating amid revenue stagnation, Syfovre challenges, and uncertain long-term profit ...
Several headwinds have pushed Regeneron 's (NASDAQ: REGN) shares lower over the past year and a half. However, the company is ...
Broadcom (AVGO) has been trading lower since reporting earnings. But it is getting close to a possible support level.
IREN Ltd (NASDAQ:IREN) shares slipped on Monday amid a broader pullback in momentum names. Here's what you need to know.
A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing ...
U.S. stock and bond markets caught a break on Monday after another unnerving AI-related shakeout late last week, with ...
Investor's Business Daily on MSN
Stocks to watch: Regeneron Pharmaceuticals sees relative strength rating rise to 82
Regeneron Pharmaceuticals earns the No. 76 rank among its peers in the Medical-Biomed/Biotech industry group. Exact Sciences ...
The big reversal in stocks on Thursday coincides with the release of long-delayed government data from September that investors were busy sifting through for clues about the economy. "I think the ...
24/7 Wall St. on MSN
Broadcom Can’t Stop Falling. Overreaction or AI Stock Warning Sign?
Broadcom (NASDAQ:AVGO) has delivered a strong performance in 2025, with shares up approximately 46% year-to-date, driven largely by demand for its artificial intelligence (AI)-related semiconductors ...
Morning Brief host Julie Hyman breaks down the biggest market stories developing on December 16, 2025. RSM chief economist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results